T-CURX GmbH
PrivateLast Round
Series A
Dec 18, 2025
Total Funding Raised
$20M
Momentum Score
75 /100
Company Overview
T-CURX GmbH is a biopharmaceutical company that develops and commercializes next-generation CAR-T cell therapies for cancer. The company, a spin-out from the University of Würzburg, utilizes a proprietary non-viral, transposon-based gene transfer technology to create more scalable and cost-effective treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
T-CURX GmbH Comps
Public and private peers based on sector, stage, and business model.
T-CURX GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 | ||||
| Grant | Jan 2, 2018 |
Key People
Founding team and executive leadership
T-CURX GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series A |
| Highlight Capital | Series A |
| Bayern Kapital | Series A |
| WuXi Biologics Healthcare Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Grew 46% QoQ, from 13 to 19 employees.
- Sep 9, 2025
Partnered with Kytopen and Fraunhofer IZI to develop advanced cell therapies.
T-CURX GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about T-CURX GmbH's valuation, stock price, and market status.
